Medicaments having controlled release of the active compound
AssigneeBayer Aktiengesellschaft
InventorsManfred Bucheler, Andreas Ohm, Roland Rupp, Josef Schmoll, Axel Wollenschlager
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer Aktiengesellschaft
InventorsManfred Bucheler, Andreas Ohm, Roland Rupp, Josef Schmoll, Axel Wollenschlager
Estimating the term…
Controlled release medicament pellets comprising a) a core which contains as active ingredient a compound of the formula ##STR1## or a compound from the group of 3-(4-fluorophenylsulphonamido)-1,2,3,4-tetrahydro-9-carbazole propanoic acid or 2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3 (2H)-one 1,1-dioxide monohydrochloride, an intensive disintegrating agent, a wetting agent and a binder, b) a double layer which controls release comprising (b1) an acrylic-based outer undigestible water-permeable lacquer layer, and (b2) an inner jacket layer comprising a hydrophobic additive and hydroxypropylcellulose of type M or H.
Pellets of a medicament having controlled release of the active compound and comprising
Dependencies are inferred from the claim text.